Cargando…
Vedolizumab for chronic antibiotic-refractory pouchitis
BACKGROUND: Chronic antibiotic-refractory pouchitis (CARP) is a complication of ileal pouch-anal anastomosis (IPAA), which poses a therapeutic challenge. Vedolizumab, a gut-selective monoclonal antibody to the α4β7 of integrin, has been used in such patients, but data on its efficacy are limited. Ou...
Autores principales: | Singh, Amandeep, Khan, Freeha, Lopez, Rocio, Shen, Bo, Philpott, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454848/ https://www.ncbi.nlm.nih.gov/pubmed/30976425 http://dx.doi.org/10.1093/gastro/goz001 |
Ejemplares similares
-
Vedolizumab in the treatment of Crohn’s disease of the pouch
por: Khan, Freeha, et al.
Publicado: (2018) -
Use of vedolizumab in a patient with chronic and refractory pouchitis
por: Orfanoudaki, Eleni, et al.
Publicado: (2018) -
Hyperbaric oxygen therapy for chronic antibiotic-refractory ischemic pouchitis
por: Nyabanga, Custon T, et al.
Publicado: (2017) -
Chronic Antibiotic-Refractory Pouchitis: Management Challenges
por: Outtier, An, et al.
Publicado: (2021) -
Rifaximin for maintenance therapy in antibiotic-dependent pouchitis
por: Shen, Bo, et al.
Publicado: (2008)